Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An intraluminal papillary neoplasm, usually with high grade intraepithelial neoplasia, that arises from the gallbladder. It is associated with the presence of an invasive carcinoma. The carcinomatous component is usually an adenocarcinoma.
Biomarker and diagnostic research for gallbladder papillary neoplasm with an associated invasive carcinoma has been reported in the published literature.
No clinical trials have been registered for gallbladder papillary neoplasm with an associated invasive carcinoma.
55 publications have been identified in PubMed for gallbladder papillary neoplasm with an associated invasive carcinoma. Research spans Case Report / Case Series (55%), Diagnostic / Biomarker (13%), and Review / Meta-Analysis (11%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 30 | 55% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 8:43 AM UTC
Testing and diagnosis research |
7 |
13% |
Research summaries | 6 | 11% |
Laboratory research | 5 | 9% |
Disease patterns and progression | 5 | 9% |
Other research | 1 | 2% |
New treatment approaches | 1 | 2% |
Li X (2026). [PMID: 41862948](https://pubmed.ncbi.nlm.nih.gov/41862948/). *Thyroid Res*. [Diagnostic / Biomarker]
Rompianesi G (2026). [PMID: 42084690](https://pubmed.ncbi.nlm.nih.gov/42084690/). *Ann Surg Oncol*. [Review / Meta-Analysis]
Szvarca D (2026). [PMID: 42270518](https://pubmed.ncbi.nlm.nih.gov/42270518/). *Hematol Oncol Clin North Am*. [Review / Meta-Analysis]
Omote R (2026). [PMID: 42185729](https://pubmed.ncbi.nlm.nih.gov/42185729/). *Clin J Gastroenterol*. [Case Report / Case Series]
Kobayashi K (2026). [PMID: 40322542](https://pubmed.ncbi.nlm.nih.gov/40322542/). *DEN open*. [Diagnostic / Biomarker]
Viehweger F (2026). [PMID: 41703255](https://pubmed.ncbi.nlm.nih.gov/41703255/). *Virchows Archiv : an international journal of pathology*. [Basic Science / Preclinical]
Arends MJ (2026). [PMID: 41724188](https://pubmed.ncbi.nlm.nih.gov/41724188/). *Histopathology*. [Review / Meta-Analysis]
Siribaddana H (2026). [PMID: 41773173](https://pubmed.ncbi.nlm.nih.gov/41773173/). *Cureus*. [Epidemiology / Natural History]
Zhang L (2026). [PMID: 41633602](https://pubmed.ncbi.nlm.nih.gov/41633602/). *Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences*. [Case Report / Case Series]
Kubota J (2026). [PMID: 41961160](https://pubmed.ncbi.nlm.nih.gov/41961160/). *Clin J Gastroenterol*. [Case Report / Case Series]